Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
0.6964
-0.0481 (-6.46%)
At close: Oct 19, 2026, 4:00 PM EDT
0.6969
+0.0005 (0.07%)
After-hours: Oct 19, 2026, 7:35 PM EDT
Bluejay Diagnostics Market Cap
Bluejay Diagnostics has a market cap or net worth of $3.11 million as of October 19, 2026. It is the 46,690th most valuable company in the world and the 6,243rd biggest in the United States. Its market cap has decreased by 27.75% in one year.
Market Cap
3.11M
Enterprise Value
-6.41M
1-Year Change
-27.75%
Global Rank
Country Rank
#6,243 United States
Category
ChartMarket Cap Chart
Since the IPO on November 10, 2021, Bluejay Diagnostics's market cap has decreased from $67.42M to $3.11M, a decrease of -95.38%. That is a compound annual growth rate of -46.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 3.11M | 157.07% |
| Dec 31, 2025 | 1.21M | -55.01% |
| Dec 31, 2024 | 2.69M | 78.09% |
| Dec 29, 2023 | 1.51M | -80.24% |
| Dec 30, 2022 | 7.65M | -84.67% |
| Dec 31, 2021 | 49.89M | -26.00% |
| Nov 10, 2021 | 67.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| enVVeno Medical | 5.10M |
| Co-Diagnostics | 4.96M |
| IceCure Medical | 4.92M |
| Intelligent Bio Solutions | 4.54M |
| Aethlon Medical | 3.66M |
| 20/20 Biolabs | 3.33M |
| INVO Fertility | 2.66M |
| WORK Medical Technology Group LTD | 2.64M |